Azeliragon CAS 603148-36-3 Alzheimer's disease anti-remission elderly APIs

1.Product Name: Azeliragon
2.Formal Name: 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-imidazol-4-yl]phenoxy]-N,N-diethyl-1-propanamine
3.CAS Number: 603148-36-3
4.Purity: 99%
5.Molecular Formula: C32H38ClN3O2
6.Molecular Weight: 532.13
7.EC Number: 814-441-9
8.Appearance: A crystalline solid
9.Synonym: 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1h-imidazol-4-yl)phenoxy)-n,n-diethylpropan-1-amine

Related Parameters:

Product Description:
Azeliragon (TTP488) is a bioavailable advanced glycation end-products (RAGE) receptor inhibitor that can alleviate the development of mild Alzheimer's disease (AD). Azeliragon can also cross the blood-brain barrier (BBB)

Function:
Inhibition of RAGE receptors: Azeliragon works by inhibiting the activity of RAGE (Advanced Glycation End-products Receptor) receptors. RAGE plays an important role in the pathogenesis of Alzheimer's disease and is involved in the production of inflammation, apoptosis and neurotoxicity.
Reducing neuroinflammation: Azeliragon has anti-inflammatory effects and can reduce neuroinflammatory responses. Inflammation is considered an important pathological feature in Alzheimer's disease, and Azeliragon reduces the progression of the disease by reducing inflammatory responses.
Improving cognitive function: Azeliragon may improve cognitive function in patients with Alzheimer's disease by regulating the release of neurotransmitters and neuronal activity. It may help improve symptoms such as memory, learning and attention.